Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Larson

Showing results (61-70 of 300) with videos related to

Pageof 30
Sort By:
Health Physics|April 11, 2009
Clearance kinetics and external dosimetry of 131I-labeled murine and humanized monoclonal antibody A33 in patients with colon cancer: radiation safety implicationsLawrence T Dauer, Daniel C Boylan, Matthew J Williamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapyBrian H Kushner, Samuel D J Yeh, Kim Kramer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
In vivo imaging of Bcr-Abl overexpressing tumors with a radiolabeled imatinib analog as an imaging surrogate for imatinibAthanasios P Glekas, Nagavara Kishore Pillarsetty, Blesida Punzalan, et al.
Journal of the American College of Surgeons|July 2, 2003
A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patientsHarvey G Moore, Tim Akhurst, Steven M Larson, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Excess Muscle FDG Uptake in an Euglycaemic Patient That Is Corrected by FastingTimothy Akhurst, Patrick Boland, Homer Macapinlac, et al.
Molecular Imaging and Biology|June 6, 2019
Imaging Sigma-1 Receptor (S1R) Expression Using Iodine-124-Labeled 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine ([<sup>124</sup>I]IPAG)Kishore K Gangangari, András Váradi, Susruta Majumdar, et al.
Nature Biotechnology|May 11, 2004
Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitorsPeter M Smith-Jones, David B Solit, Timothy Akhurst, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
FDG-PET in Esophageal Cancer. Incremental Value over Computed TomographyHenry W.D. Yeung, Homer A. Macapinlac, Madhu Mazumdar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patientsHeiko Schöder, Yusuf E Erdi, Kenneth Chao, et al.
Cancer Research|December 20, 2007
In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter geneMikhail M Doubrovin, Ekaterina S Doubrovina, Pat Zanzonico, et al.
Pageof 30

Showing results (61-70 of 300) with videos related to

Sort By:
Pageof 30
Health Physics|April 11, 2009
Clearance kinetics and external dosimetry of 131I-labeled murine and humanized monoclonal antibody A33 in patients with colon cancer: radiation safety implicationsLawrence T Dauer, Daniel C Boylan, Matthew J Williamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapyBrian H Kushner, Samuel D J Yeh, Kim Kramer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
In vivo imaging of Bcr-Abl overexpressing tumors with a radiolabeled imatinib analog as an imaging surrogate for imatinibAthanasios P Glekas, Nagavara Kishore Pillarsetty, Blesida Punzalan, et al.
Journal of the American College of Surgeons|July 2, 2003
A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patientsHarvey G Moore, Tim Akhurst, Steven M Larson, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Excess Muscle FDG Uptake in an Euglycaemic Patient That Is Corrected by FastingTimothy Akhurst, Patrick Boland, Homer Macapinlac, et al.
Molecular Imaging and Biology|June 6, 2019
Imaging Sigma-1 Receptor (S1R) Expression Using Iodine-124-Labeled 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine ([<sup>124</sup>I]IPAG)Kishore K Gangangari, András Váradi, Susruta Majumdar, et al.
Nature Biotechnology|May 11, 2004
Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitorsPeter M Smith-Jones, David B Solit, Timothy Akhurst, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
FDG-PET in Esophageal Cancer. Incremental Value over Computed TomographyHenry W.D. Yeung, Homer A. Macapinlac, Madhu Mazumdar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patientsHeiko Schöder, Yusuf E Erdi, Kenneth Chao, et al.
Cancer Research|December 20, 2007
In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter geneMikhail M Doubrovin, Ekaterina S Doubrovina, Pat Zanzonico, et al.
Pageof 30